Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Levered Free Cash Flow (FCF)

Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) for the quarter ending September 09, 2020 was $1,561m a 47.15% increase of 736m year over year
  • Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2020 was $14,974m a 58.89% increase of 8,818m year over year
  • Bristol-Myers Squibb Company Annual Levered Free Cash Flow (FCF) for 2019 was $6,156m a 47.77% increase of 2,941m from 2018
  • Bristol-Myers Squibb Company Annual Levered Free Cash Flow (FCF) for 2018 was $3,215m a 33.72% increase of 1,084m from 2017
  • Bristol-Myers Squibb Company Annual Levered Free Cash Flow (FCF) for 2017 was $2,131m a 33.76% increase of 720m from 2016
Other Cash Flow Metrics:
  • Bristol-Myers Squibb Company Cash Flow from Operations for the quarter ending September 09, 2018 was $1,279m a 12.67% increase of 162m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY Levered Free Cash Flow (FCF) Data

09/2020$1,561m
06/2020$7,968m
03/2020$4,539m
12/2019$825m
09/2019$2,490m
06/2019$1,645m
03/2019$1,194m
12/2018$770m
09/2018$656m
06/2018$1,512m

Annual BMY Levered Free Cash Flow (FCF) Data

2019$6,156m
2018$3,215m
2017$2,131m
2016$1,412m
2015$3,320m
2014$5,441m
2013$-478m
2012$2,889m
2011$5,301m
2010$4,357m